Closing: 5.00 pm on Thursday 21 December 2023.
Reopening: 9.00 am on Monday 8 January 2024.
We wish you all a merry and safe Christmas and New Year.
Behind every Purifas product, extensive clinical design and testing ensures what you're using is the best for your practice and customers.
Our testing indicates that the FaceShield significantly reduces the transmission of bacteria onto the therapy bed between each patient, making it the superior product of its kind.
Further information regarding our clinical testing can be found here.
Purifas highly regards the opinion of our customers, and so we conducted our own market research to find out what is important to them.
The data shows:
Please see our downloadable content available FREE for your business.
WORLD'S FIRST RESEARCH ― A significant amount of government funding is consistently allocated to research into infection risks and prevention in hospital environments, however, the same can't be said for therapy environments. This lack of research prompted us to commission our own preliminary research into the infection risks associated with therapy beds, with a focus on the transmission of both bacteria and saliva. The results are in and they will shock you!